Cities Changing Diabetes features prominently in an article published
this week on Canada's Globe and Mail website on how public-private
partnerships (P3) can alleviate the stress of chronic disease on the
health system. The feature article builds on a webinar in early May in
which Cities Changing Diabetes shared the stage with the Raven
Indigenous Capital Partners, an impact investor in socially
responsible projects, and speakers from the University of
Toronto.
The article points to shared commitment and longevity as important
attributes of successful P3 initiatives. Lisa Mitchell, president and
CEO of the Canadian Council for Public-Private Partnerships, says in
the article: “The shared responsibility between governments, private
industry and philanthropic organisations incentivises private-service
providers to stay on target and within budget, which protects
taxpayers with a return on investment far into the future.”
Adam Marsella, director of external affairs, Novo Nordisk
Canada, adds: “The issue of diabetes is so broad and challenging that
no single stakeholder could tackle it on their own. We are in this for
the long-term benefit and try to bring in partners with the same
vision.”
You can find the article here.
